nuclear matrix protein 22 in urine
Jump to navigation
Jump to search
Indications
- screening for bladder cancer
Clinical significance
- point of care proteomics test for nuclear matrix protein NMP22
- can be read in 30-50 minutes
- Sensitivity: 56% (vs 16% for cytology)
- Specificity: 86% (vs 99% for cytology)
- Positive predicitive value: 20% (vs 55% for cytology)
- Positive predicitive value: 97% (vs 95% for cytology)
More general terms
Additional terms
References
- ↑ Journal Watch 25(7):57, 2005 Grossman HB, Messing E, Soloway M, Tomera K, Katz G, Berger Y, Shen Y. Detection of bladder cancer using a point-of-care proteomic assay. JAMA. 2005 Feb 16;293(7):810-6. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15713770
- ↑ NMP22 Laboratory Test Directory ARUP: http://www.aruplab.com/guides/ug/tests/0080281.jsp